This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Overweight and Obesity
and you are
between 21 and 75
years old
The phase for this study is not defined.
Show me locations

The purpose

The polyglucosamine, specification L112 is a medical device and in this clinical trial used for weight reduction of overweight and obese participants. The rationale for this study is to show that overweight can be reduced by taking 2 times daily 2 tablets with the main meals with the highest fat content.

Provided treatments

  • Device: Polyglucosamine
  • Other: Placebo
Tris trial is registered with FDA with number: NCT02410785. The sponsor of the trial is Certmedica International GmbH and it is looking for 115 volunteers for the current phase.
Official trial title:
Efficacy of Polyglucosamine for Weight Loss - in a Randomized, Double-blind, Placebo-controlled Clinical Investigation